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Abstract
Background: Far-infrared ray (FIR) has been widely used in promoting health and has been shown to exert
beneficial effects in vascular function. The non-thermal effect of FIR has been found to play a significant role in the
protective effect on some vascular-related diseases, but its protective effects and use against hypertension have not
been clearly presented.
Methods: In the present study, by using a wooden board coated with FIR-irradiated materials, we evaluated the
long-term antihypertensive effect on spontaneously hypertensive rats (SHRs) in the environment in contact with the
FIR-irradiated wooden board. SHRs were placed on the wooden board with or without FIR radiation for 4 weeks.
Results: The systolic blood pressure (BP) of SHRs undergoing different treatments was measured weekly using a
tail-cuff method. FIR radiation significantly reduced the systolic BP of the SHRs along with a decreasing plasma level
of angiotensin II and an increasing plasma level of bradykinin. In addition, long-term contact of FIR did not
significantly affect the BP in normotensive Wistar Kyoto rats (WKYs).
Conclusions: Our results provided the evidence based on which FIR radiation could be considered an effective
non-pharmacological choice for preventing hypertension.
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Background
Hypertension, the persistent increase of blood pressure (BP)
above 140/90 mmHg, is a major risk factor for the develop-
ment of cardiovascular disease, including stroke, myocardial
infarction, heart and renal diseases, and cardiac mortality.
Although the etiology of hypertension is complex, the
renin-angiotensin system (RAS) plays a major role in the
pathology of hypertension [1, 2]. Renin catalyzes the conver-
sion of angiotensinogen to angiotensin I, which is the rate-
determining step. Angiotensin-converting enzyme (ACE)
then catalyzes the conversion of angiotensin I to angioten-
sin II, leading to the constriction of the arterial vessels and
the regulation of systemic BP [3]. Since the increased
levels of angiotensin II are closely related to the devel-
opment and maintenance of hypertension, the inhib-
ition of angiotensin II formation has been widely
considered a major strategy for lowering BP in patients
with hypertension [4, 5]. Because sustained BP eleva-
tion may increase the incidence of atherosclerosis and
stroke, it is important to develop alternative strat-
egies for the treatment of hypertension.
The far-infrared ray (FIR) is generally defined as the elec-
tromagnetic wave in the wavelength range of 5.6–1000 μm.
FIR radiation has been widely applied to a variety of fields
as it has positive effects on food preservation [6], health
promotion [7], and cardiovascular systems [8, 9]. Some
studies indicated that FIR therapy has potentially beneficial
effects in the treatment of wound healing [10], diabetes
[11], tumor thermal therapy [12], chronic fatigue syndrome
[13], and knee osteoarthritis [14]. In addition, several
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studies also indicated that FIR radiation exerts beneficial
effects in the treatment of vascular diseases. FIR radiation
improved impaired vascular endothelial function in patients
with heart disease [15], decreased endothelial inflammation
by induction of heme oxygenase-1 [16], and augmented
angiogenesis in the ischemic hind limb [11]. These studies
revealed that the potential effects of FIR therapy played a
significant role in the protective effect on vascular function.
There is an increasing evidence that the secretion of
soluble inflammatory makers play a significant role in
hypertension [17, 18]. Soluble intercellular adhesion
molecule 1 (sICAM-1), vascular adhesion molecule 1
(sVCAM-1), and sE-selectin are major inflammatory
markers and endothelial cell adhesion molecules that
regulates the binding and extravasation of leukocytes
from the bloodstream to sites of inflammation [19].
The appearance of soluble inflammatory markers in the
circulation is thought to be the consequence of their
release from the vascular cells because of increased
expression [20].
The spontaneous hypertension rats (SHRs) are the
most widely used animal model in the study of
hypertension-related diseases. The duration, cardiac
hypertrophy, renal dysfunction, and cardiovascular
complications of SHRs are similar to those observed
in human hypertension. In this study, by using the
wooden board coated with FIR-emitting materials, we
evaluated the long-term effect on SHRs in contact
with the FIR-emitting wooden board. Wistar Kyoto
rats (WKYs) were used as the control group. These
findings provide new insights into the treatment of
hypertension using FIR radiation.
Methods
The FIR-irradiated wooden board
All of the FIR-irradiated wooden board (53 × 21.5 × 1.5 cm;
length ×width × thickness) samples used in this study were
made by Ua Wood Floors, Inc. (Yunlin, Taiwan). The
wooden boards were coated with Nano-paste (ZnO), which
was manufactured by Nano-Infinity Nanotech Co., Ltd.
(Taoyuan, Taiwan). Using the far-infrared ray testing system
(Bruker, VERTEX 70 FT-IR) to test for far-infrared emissiv-
ity, the spectrums of the FIR-irradiated wooden board
exhibited high emissivity (>0.8) between 4 ~ 14 μm wave-
lengths (triplicate samples were made for each wooden
board, with measurements done by Industrial Technology
Research Institute in Taiwan).
Animal model
The study was performed in accordance with the guide-
lines for laboratory animals of National Chiayi University.
The protocol was approved by the Institutional Animal
Care and Use Committee of National Chiayi University.
All efforts were made to minimize suffering. Eight-
week-old male SHRs and WKYs were obtained from
the National Laboratory Animal Breeding and Research
Center of the National Science Council, Taiwan. All rats
were maintained five per cage at a constant temperature
(24 ± 1 °C), with a 12-h dark/light cycle and a standard rat
chow diet. After the SHRs had been housed for 10 weeks,
their weight ranged from 240–250 g, and systolic BP
reached 180 mmHg. The rats were randomly divided into
four groups (n = 10 per group). Group 1: SHRs on a
wooden board without FIR radiation as the control group;
group 2: SHRs on a wooden board with FIR radiation;
group 3: SHRs on a normal wooden board with atenolol
administration as the positive control group; and group 4:
SHRs on an FIR-radiated wooden board with atenolol
administration. In addition, the WKY rats were di-
vided into group 1 and group 2 for comparing the
SHRs in this study.
Measurement of BP
BP was measured indirectly and non-invasively every
week by using the volume-oscillometric tail-cuff method
(UR-5000, UEDA, Industries Co., Tokyo, Japan). To get
an accurate BP, at least 7 consecutive determinations
were recorded. The maximum and minimum values of
BP were then eliminated, and the BP was calculated as
the average of the remaining values [21].
Analysis of plasma angiotensin II, bradykinin, and ACE
activity
After animal sacrifice, blood samples were collected
and kept on ice. The samples were collected and cen-
trifuged at 3000 rpm for 15 min at 4 °C. The plasma
was stored at−80 °C until analysis. Both angiotensin
II and bradykinin were quantified by respective ELISA
kits (Angiotensin II ELISA, Cayman Chemical, Ann
Arbor, MI, USA; Bradykinin ELISA, Phoenix Phar-
maceuticals, Burlingame, CA, USA) as per the manu-
facturers’ instructions. ACE activity was determined
according to the colormetric method using synthetic
sybstrate (FAPGG) [22]. One unit (U) of ACE acitvity
is defined as the amount of which released 1 μmol of
His-Leu per minute. The specific activity of ACE is
expressed as U/L.
Analysis of plasma inflammatory markers
The levels of sICAM-1, sVCAM-1, and sE-selectin in
plasma were determined by using sandwich ELISA
(R&D Systems, Minneapolis, MN) according to manu-
facturer’s protocols [23].
Statistics analysis
Data were reported as the mean ± standard error of the
means (SEM) and evaluated by one-way analysis of vari-
ance. Significant differences were established at P < 0.05.
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Results
FIR-irradiated wooden board attenuates BP in SHRs
The SHRs demonstrated already established hyperten-
sion at the beginning of the study (week 0). The results
from this study, as illustrated in Fig. 1a, demonstrated
that at the start of the experiment, the mean values of
systolic BP in all the SHRs were similar (174.5 to
179.6 mmHg). The systolic BP in the control SHRs was
increased up to 193.6 mmHg at the end of the 4-week
period of experiment, whereas SHRs on an FIR-
irradiated wooden board started to reduce systolic BP
after 1 week, and this effect continued until the 4-week
experimental period with gradual reduction in systolic
BP. Among the treatment, SHR administration with
atenolol reduced the systolic BP more significantly at
week 3 and 4 compared with the SHRs treated with FIR
only. There were no obvious changes in the systolic BP
in WKYs with or without FIR irradiation (Fig. 1b). These
experiments suggested that the effect of FIR irradiation
on SBP levels has specificity against hypertensive rats.
FIR irradiation inhibits plasma ACE activity in SHRs
Plasma ACE activity in the SHR untreated group was
significantly higher than in the WKY group (35.4 ± 3.1
vs. 124.5 ± 8.4 U/L). FIR irradiation decreased ACE
activity in the SHR untreated group to 76.7 ± 6.3 U/L in
the FIR-irradiated group (Fig. 2). In addition, SHR
administration with atenolol further reduced the plasma
ACE activity compared with the SHRs treated with FIR
only (Fig. 2).
FIR irradiation appears to inhibit angiotensin II in vivo
The effect of FIR irradiation on the systolic BP of the
SHRs was associated with concomitant changes in circu-
lating levels of angiotensin II and bradykinin. FIR irradi-
ation decreased angiotensin II levels from 48.2 ± 5.4 pg/
mL in the untreated group to 30.5. ± 3.1 pg/mL in the
FIR-irradiated group (Fig. 3). In addition, SHR adminis-
tration with atenolol further reduced the angiotensin II
levels compared with the SHRs treated with FIR only
(Fig. 3). The treatment also increased the circulating
levels of bradykinin (a molecule metabolized by ACE),
which increased from 1.82 ng/mL in the untreated group
to 3.05 ng/mL in the FIR irradiated group (Fig. 4). More-
over, the WKY rats had the lowest angiotensin II (Fig. 3)
and the highest bradykinin (Fig. 4) levels, compared to
all the SHR groups. These results suggest that FIR irradi-
ation may decrease the production of angiotensin II as
Fig. 1 Changes in systolic BP of experimental rats during the 4-week
period. a The SHRs were randomly divided into four groups (n = 10
per group). Group 1: SHRs on a wooden board without FIR radiation
as the control group (control); group 2: SHRs on a wooden board
with FIR radiation (FIR); group 3: SHRs on a normal wooden board
with atenolol administration as the positive control group (atenolol);
and group 4: SHRs on an FIR-radiated wooden board with atenolol
administration (FIR + atenolol). b The WKY rats were randomly
divided into two groups (n = 10 per group). Group 1: WKYs on a
wooden board without FIR radiation as the control group (control);
and group 2: WKY rats on a wooden board with FIR radiation (FIR).
Data are mean ± SEM. *p < 0.05 vs. control SHRs, #p < 0.05 vs. SHRs
with FIR irradiation
Fig. 2 Plasma ACE activity of experimental rats after the 4-week
treatments. WKYs: WKYs on a wooden board without FIR radiation;
CL: SHRs on a wooden board without FIR radiation; FIR: SHRs on a
wooden board with FIR radiation; atenolol: SHRs on a normal
wooden board with atenolol administration; FIR + atenolol: SHRs on
an FIR-radiated wooden board with atenolol administration.
Data are mean ± SEM from n = 10 animals per treatment group.
*p < 0.05 vs. control SHRs, #p < 0.05 vs SHRs with FIR irradiation,
†p < 0.05 vs. WKY group
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well as inhibit the degradation of bradykinin, thereby
decreasing the systolic BP in SHRs.
FIR irradiation ameliorates plasma levels of inflammatory
markers
We further evaluated the effect of FIR irradiation on
plasma levels of sICAM-1, sVCAM-1, and sE-selectin in
SHRs. SHR untreated group exhibited an increase in
sICAM-1, sVCAM-1, and sE-selectin levels compared to
WKY rats (Fig. 5). However, SHRs treated with FIR
showed decreased sICAM-1, sVCAM-1, and sE-selectin
levels compared to untreated group (Fig. 5).
Discussion
Recent findings showed that FIR radiation might play a
role in the long-term protective effect on vascular func-
tion by reducing several cardiovascular risk factors such
as high BP. Our studies with FIR irradiation in SHRs
demonstrated for the first time that rats placed on FIR
irradiated wooden board indeed showed a systolic BP
reducing effect in the hypertensive rats in a time-
dependent manner. The FIR also decreased angiotensin
II and increased bradykinin production in the plasma of
the treated SHRs, suggesting the possible mecha-
nisms for the systolic BP reducing effect of FIR.
Thus, FIR could prove to be a novel method for
management of hypertension.
SHRs are the animal model most frequently used to
evaluate the in vivo antihypertensive effect of different
treatments such as drugs or dietary components. Various
studies performed to determine the antihypertensive
effects of food-derived bioactive peptides have used SHR
animals as a model system [24, 25]. To verify the validity
of the experimental protocol, both a negative and a
positive control group were included. The underlying
pathological mechanisms of the hypertensive effect in
SHRs include increased activity of the renin-angiotensin
system as well as increases in vascular inflammation and
oxidative stress [26, 27]. Hence, SHRs are a suitable
model to study the in vivo antihypertensive efficacy of
FIR irradiation. In the present study, systolic BP in-
creased in the control SHR group during the 4-week
period of the study. In addition, the systolic BP was
significantly decreased in the positive control group
(which received atenolol administration) when compared
to the negative control group. Thus, the negative and
positive control groups confirmed the validity of the
animal model chosen in this study.
The increase in BP is directly due to the vasoconstrict-
ive actions of angiotensin II produced from angiotensin
I in the presence of ACE [28, 29]. Angiotensin II signifi-
cantly increased the BP by the activation of angiotensin
II receptors in the vascular smooth muscle cells, result-
ing in increased vasoconstriction, decreased renal blood
flow and renal tubular sodium re-uptake, and increased
vasopressin secretion [30–32]. In our present study, FIR
radiation appears to act through angiotensin II, leading
to lowered BP in SHRs. FIR radiation reduced the
plasma and angiotensin II levels with a corresponding
increase in bradykinin. The plasma levels of ACE activity
tended to be positively related to BP changes, which is
consistence with the earlier work that have shown that
ACE levels could be used as a hypertension marker in
Fig. 3 Plasma angiotensin II levels of experimental rats after the
4-week treatments. WKYs: WKYs on a wooden board without FIR
radiation; CL: SHRs on a wooden board without FIR radiation; FIR:
SHRs on a wooden board with FIR radiation; atenolol: SHRs on a
normal wooden board with atenolol administration; FIR + atenolol:
SHRs on an FIR-radiated wooden board with atenolol administration.
Data are mean ± SEM from n = 10 animals per treatment group.
*p < 0.05 vs. control SHRs, #p < 0.05 vs SHRs with FIR irradiation,
†p < 0.05 vs. WKY group
Fig. 4 Plasma bradykinin levels of experimental rats after the 4-week
treatments. WKYs: WKYs on a wooden board without FIR radiation;
CL: SHRs on a wooden board without FIR radiation; FIR: SHRs on a
wooden board with FIR radiation; atenolol: SHRs on a normal
wooden board with atenolol administration; FIR + atenolol: SHRs on
an FIR-radiated wooden board with atenolol administration. Data are
mean ± SEM from n = 10 animals per treatment group. *p < 0.05 vs.
control SHRs, #p < 0.05 vs. SHRs with FIR irradiation, †p < 0.05 vs.
WKY group
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SHRs [33]. Our result is further confirmed by the fact
that FIR-irradiated SHRs had significantly reduction
of plasma ACE activity when compared to the un-
treated control, suggesting a role of elevated plasma
ACE activity in modulating hypertension conditions.
Thus, the antihypertensive effects of FIR radiation
may be mediated by downregulation of ACE with a
consequent reduction in the plasma levels of the
vasoconstrictor angiotensin II.
It has been showed that FIR therapy has been ap-
plied to various clinical fields, particularly including
vessel-related disorders [34]. FIR radiation enhanced
blood flow retrieval and blood vessel formation in
ischemic hind limbs by enhancing the homing of
endothelial progenitor cells and lowering the oxidative
stress in ischemic tissue. Direct FIR radiation could
also ameliorate high-glucose-induced oxidative stress,
suppress cellular senescence, and improve endothelial
progenitor cell functions [11]. Although the mechanism
by which FIR radiation has a potential for the treatment of
vascular diseases is still unclear, the improvement of endo-
thelial cell function is currently considered as a mechan-
ism [35]. In addition, increasing evidence suggests FIR
therapy could exert beneficial effects in the cardiovascular
system through the NO-related pathway [36]. FIR therapy
could upregulate eNOS expression and increase angiogen-
esis in an apolipoprotein E-knockout mouse model [37].
These findings suggest that FIR may provide some
novel rationales for its potential clinical impact on
vascular protection.
Vascular dysfunction or damage can be evaluated by
the measurement of inflammatory markers released
from vascular cells, such as sICAM-1, sVCAM-1, and
sE-selectin [38]. Several studies have demonstrated that
the plasma levels of inflammatory markers are increased
in patients with hypertension, type 2 DM, and athero-
sclerosis, all of which are well-established risk factors for
cardiovascular diseases [39–41]. Higher levels of soluble
inflammatory markers are associated with increased
cardiovascular risk in hypertension, presumably because
such high levels reflect chronic, low-grade vascular
inflammation [18]. FIR therapy has been reported to
exert a potent anti-inflammatory effect via induction of
HO-1 release by human umbilical vein endothelial cells
[16]. Down-regulation in these markers may confer a
decrease in cardiovascular risk, although prospective
data are needed to test this hypothesis. In the current
study, FIR irradiation decreased levels of the inflam-
matory markers sICAM-1, sVCAM-1, and sE-selectin,
suggesting a specific anti-inflammatory property of FIR
in vivo. Since SHR untreated group has increased levels
of plasma inflammatory markers which may contribute
to endothelial dysfunction, it is suggested that control-
ling the inflammatory responses with FIR irradiation
could potentially improve the vascular function and
reduce inflammation.
Fig. 5 Plasma sICAM-1 (a), sVCAM-1 (b), and sE-selectin (c) levels of experimental rats after the 4-week treatments. WKYs: WKYs on a wooden
board without FIR radiation; SHR-CL: SHRs on a wooden board without FIR radiation; SHR-FIR: SHRs on a wooden board with FIR radiation. Data
are mean ± SEM from n = 10 animals per treatment group. *p < 0.05 vs. WKY group, #p < 0.05 vs. SHRs with FIR irradiation
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Conclusions
This study provides evidence of the antihypertensive
effect of FIR irradiation in SHRs. We found that the
treatment of SHRs with FIR irradiation induced a
decrease in BP. Since FIR substantially decreased the
SHR plasma ACE activity and angiotensin II level, and
increased the bradykinin level, we believe that the mech-
anism of the antihypertensive effect of FIR on SHRs may
be related to the ACE inhibitory effect. Our results suggest
a possible beneficial effect of FIR on cardiovascular func-
tion and thus provide a mechanistic basis for the use of
FIR as an antihypertensive remedy in folk medicine.
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